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Abstract: Human cystatin C (HCC), a cysteine-protease inhibitor, exists as a folded monomer under
physiological conditions but has the ability to self-assemble via domain swapping into multimeric
states, including oligomers with a doughnut-like structure. The structure of the monomeric HCC
has been solved by X-ray crystallography, and a covalently linked version of HCC (stab-1 HCC) is
able to form stable oligomeric species containing 10–12 monomeric subunits. We have performed
molecular modeling, and in conjunction with experimental parameters obtained from atomic force
microscopy (AFM), transmission electron microscopy (TEM) and small-angle X-ray scattering (SAXS)
measurements, we observe that the structures are essentially flat, with a height of about 2 nm,
and the distance between the outer edge of the ring and the edge of the central cavity is ~5.1 nm.
These dimensions correspond to the height and diameter of one stab-1 HCC subunit and we present
a dodecamer model for stabilized cystatin C oligomers using molecular dynamics simulations and
experimentally measured parameters. Given that oligomeric species in protein aggregation reactions
are often transient and very highly heterogeneous, the structural information presented here on
these isolated stab-1 HCC oligomers may be useful to further explore the physiological relevance of
different structural species of cystatin C in relation to protein misfolding disease.
Keywords: cystatin C; oligomers; domain swapping; protein misfolding
1. Introduction
Human cystatin C (HCC), containing 120 amino acids, belongs to the cystatin type 2 superfamily [1,2],
and is a potent inhibitor of papain-like (C1) and legumain-like (C13) cysteine-proteases [3,4]. In humans,
HCC was originally identified in cerebrospinal fluid (CSF), but has subsequently been found in other
bodily fluids and tissues [5–7]. The wild-type (WT) form of HCC is a component of amyloid deposits in,
mostly elderly, patients with sporadic cerebral amyloid angiopathy [8]. Interestingly, the L68Q variant
of HCC is associated with a rare hereditary cystatin C amyloid angiopathy, where the protein forms
amyloid deposits in patients suffering from hereditary cerebral hemorrhage with amyloidosis [8–10].
To date, the crystal structures of monomeric and dimeric WT HCC have been characterized, the latter
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in two polymorphic forms [11–13], along with monomeric and dimeric crystal structures of several
HCC mutational variants [14,15]. Under physiological conditions, WT HCC is a monomer, but
when crystallized the protein readily forms domain-swapped dimers, and when subjected to mildly
destabilizing solvent conditions, it forms a number of oligomeric states and fibrils through this
domain-swapping phenomenon [12,16]. An engineered variant of cystatin C (stab-1 HCC), which
contains an additional disulfide bridge (L47C-G69C), stabilizes the monomeric form of the protein and
reduces the ability of the protein to form fibrils [14,17]. Stable oligomeric species of stab-1 HCC can be
formed following incubation of high concentrations of monomeric protein at pH 7.4 in the presence of
1 M guanidinium hydrochloride and the reducing agent, dithiothreitol [16]. These oligomers can be
separated by size-exclusion chromatography (SEC) and are SDS-resistant but reducing agent-sensitive,
suggesting that intermolecular disulfide bonds stabilize the oligomers. By gel electrophoresis analysis,
it is possible to isolate oligomers that have molecular weights which correspond to the size-range
for decamers to dodecamers. These oligomer species do not retain their ability to inhibit papain-like
cysteine proteases, which indicates that the N-terminal loops 1 and 2 are not accessible, suggesting that
these oligomers are formed via a domain-swapping mechanism [16].
Interestingly, the A11 antibody, designed to bind to soluble oligomers of the Aβ peptide, whose
aggregation is associated with Alzheimer’s disease, is able to recognize a number of oligomeric species
composed of different peptides and proteins [18], and has a weak affinity for the doughnut-like
cystatin C oligomers [16]. This observation suggests that structural commonalities exist within different
oligomeric species and, therefore, detailed structural analysis of oligomers from an array of proteins is
likely to prove to be insightful for understanding specific mechanisms of protein misfolding. At present,
there are approximately 50 diseases linked to protein misfolding and amyloid deposition, including
neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, transmissible spongiform
encephalopathies (TSEs), and non-neuropathogenic conditions such as systemic amyloidosis and type
II diabetes [19,20]. Although the primary and tertiary structures of the functional states of the peptides
and proteins involved with these diseases are diverse, a hallmark of these disorders is the deposition
of fibrillar structures which are remarkably similar [21].
The process of fibril formation involves a heterogeneous mixture of different aggregated species,
including the mature fibrils, protofibrils and smaller, oligomeric species [22,23]. Given that oligomer
species are often transient, heterogeneous in nature and hard to isolate, many methods for producing
stabilized oligomeric species have been employed with different protein substrates. These methods
include the use of chemical crosslinking [24], altering ionic strength and buffer conditions [25],
using lyophilization [26] and through chemical modifications [27]. These well-defined oligomer
species have been used to search for structural attributes that may be important for pathogenicity,
and increasing evidence has suggested that these oligomeric species are likely to be responsible for
cellular toxicity through interactions and disruption of cellular membranes [18,28–30]. Structural
characterization of a range of such oligomer species have shown that they can adopt a number of
morphologies, including spherical beads (2–5 nm in diameter), beaded chains, curly chains and
ring-shaped (doughnut-like) structures [19,20]. Though less commonly observed than other types of
structures, doughnut-like oligomeric forms have been reported for human cystatin C (HCC) [31] and
other amyloidogenic proteins, including α-synuclein, the amyloid β (Aβ) peptide and immunoglobulin
light chains [32–34].
The aim of this present study is to define a structural model of the stable human cystatin C oligomers
by combining information from the crystal structure of monomeric stab-1 HCC [14], along with
experimental measurements of the oligomers obtained using transmission electron microscopy (TEM),
atomic force microscopy (AFM) and small-angle X-ray scattering (SAXS) techniques, with molecular
dynamics (MD) simulations. Using these techniques, we propose a dodecamer model of the stab-1
cystatin C oligomers.
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2. Results
2.1. Overall Morphology of the Stab-1 HCC Oligomers
TEM and AFM images were used to determine the overall geometric parameters of the stab-1 HCC
oligomers that were isolated from size exclusion chromatography and correspond to 10–12 subunits.
These samples provided the reference data for the construction of the initial molecular models of the
oligomers. Representative TEM images, illustrating the morphology of the oligomers, are shown in
Figure 1. It is clear that a number of small, ring-like aggregates are present within the sample and that
the predominant species appear to be approximately circular, having a diameter of 20–30 nm with a
distinctive central cavity, in agreement with previous observations [31]. Some larger oligomers, of the
order of 50 nm in diameter, and also the occasional short fibrillar species (Figure 1) can be observed,
though much less frequently. Analysis of numerous TEM images at higher resolution (Figure 2) again
reveals examples of circular, doughnut-shaped oligomers with differing sizes, with the smallest about
16–17 nm in diameter (d1) and the largest are about 20–24 nm. For the oligomers analyzed in detail,
the distance between the edge of the central cavity and the inner edge of the outer ring (d2) is quite
similar (~5–6 nm) (Figure 2); this value corresponds very well to the cross-sectional diameter of one
cystatin C molecule in the crystal structure [14].
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(D)) and higher molecular weight oligomers (red circles, panels (C,D)) are also evident. Scale bars are
100 nm in each case.
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Figure 2. Selected stab-1 HCC doughnut-like images of oligomers obtained from TEM data.
Top, enlargement of the images of stab-1 HCC oligomers observed by TEM. The diameter is indicated
by “d1” and the distance between the inner and outer rings defined as “d2”. Bottom, variations in d1
and d2 are likely to be due to the differences in the electron density of the contrasting uranyl acetate
adsorbed to the oligo er surface. Scale bars are 10 n in each case.
complement the TEM analysis, we used atomic force microscopy (AFM) to provide inde endent
evidence about the overall morphology of the stab-1 HCC oligomers and als to determine the
h ights of individual oligomers. Representative AFM imag s are shown in Figure 3, with th
predominant species displaying the spherical morphology observed in the majority of the TEM images.
he cross-sectional profil s (Figure 3, right panel) indicate that these circul r oligomers have height
in the range of 1.6 to 2.5 nm and diameters of 20–30 nm, which is slig tly larger than what w s
observed by TEM. However, the AFM measurements w re not calibrated to give accurate XY plan
measurements in these experiments and, therefore, these diamet rs may be over-estimated. The height
measurement of the olig mers were therefo aken f om the AFM studies, and the values for the
diameters w r bas d on the TEM measurements.
l str cture of the stab-1 HCC monomer shows that the protein molecule has diameter of
approximately 2.5–3.0 nm (excluding the hydration shell on the protein surface) (PDB code: 3GAX) [14].
Despit the possibility of err rs in the heights mea ur d by AFM as a result of strong adhesion to the
mica surface, the valu of 2 nm corresp nd t a single layer of stab-1 HCC subunits.
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Figure 3. Topogra hy of the stab-1 HCC oligomers. S lected AFM images of the stab-1 HCC oligomers
(A,B) and cross-sectional profiles of the indicated oligomers in the images (C,D). The heig t profiles
(z (nm)) are presented for the indicated oligomers from panel (A) (1–3) and panel (B) (1, 2). From this
analysis the diameter (x (nm)) can be approximated.
2.2. Structural Parameters of the Stab-1 HC Oligo ers in Solution
SAXS studies of the stab-1 HCC oligomers in solution involved the use of synchrotron radiation
which has a risk of causing a reduction in the disulfide bridges that stabilize the overall structure
of the HCC subunits and also the oligomers. We know that human cystatin C and its variants are
sensitive towards synchrotron radiation and prone to aggregation [35]. A detailed inspection of each
of the recorded frames was therefore carried out and only those frames that did not show an evidence
of radiolysis were selected for further analysis. The radius of gyration (Rg) for the oligomers was
determined by fitting the SAXS data (Supplementary Figure S1) to the Guinier equation. The result of
the analysis gives a value for Rg of 5.28 ± 0.13 nm.
As a consequence of the limited s-range of the SAXS data due to the low available protein
concentrations and some size polydispersity, a degree of heterogeneity is likely to exist. For these
reasons, we were not able to conduct ab initio modeling but instead defined the geometric parameters
of the flattened doughnut-like structure, which best depicts the stab-1 HCC oligomers using the
universal Rg calculator [36]. These calculations indicate that the outer diameter of the doughnut-like
structure is 20–23 nm, the height is 2.4–2.6 nm and the inner diameter is 7–8 nm. These values are
consistent with the height and diameter param t rs dete mined for a single stab-1HCC subunit of
16–24 nm (outer di meter) and 1.6–2.5 nm (height), obtained f om TEM and AFM measurements.
This infor ation was therefore used to define reference parameters for the construction of the initial
models of the stab-1 HCC doughnut-like oligomers, which were required as input into to molecular
dynamics simulations (Table 1).
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Table 1. Summary of structural parameters of the stab-1 HCC oligomers obtained by different
experimental methods.
Outer Diameter (nm) Inner Diameter (nm) * Height (nm)
TEM 16–24 5–6 -
AFM 20–30 - 1.6–2.5
SAXS 20–23 7–8 2.4–2.6
* The inner diameter is defined as the distance between the outer edge of the internal cavity and the outer edge of
the whole ring structure.
2.3. Preliminary Models of the Stab-1 HCC Oligomers
Two subtypes of stab-1 HCC oligomers, the decamers and dodecamers, were selected for molecular
modeling on the basis of the geometric parameters, derived from TEM, AFM and SAXS data (Table 1),
and also on criteria based on previously published biochemical studies [16]. It has been shown
previously that the stab-1 HCC oligomers are not capable of inhibiting the protease papain, indicative
of the papain-binding site (N-terminal loops 1 and 2) being buried within the oligomer structure,
whereas the oligomers are still capable of inhibiting the activity of legumain, confirming that this part
of the cystatin C structure is still available for protease-binding [16]. As these earlier studies strongly
suggest that the domain-swapped dimeric structure is maintained, this was incorporated after selection
from the initial modeling. For both the decamer and dodecamer oligomers, a geometric alignment of
the HCC subunits using the stab-1 HCC monomeric crystal structure (PDB: 3GAX) and the SymmDoc
platform [37] was performed. From a pool of 100 potential structures for each oligomer type obtained in
this way, the models were grouped manually into five subfamilies (containing 2–12 models) differing
to a small degree in the relative positions of the subunits.
Some of the models selected did not match the geometric parameters defined by the TEM, AFM and
SAXS experimental data and these models were not taken forward into the molecular dynamics simulations;
this eliminated a significant number of potential structures that contained inconsistent orientations of
monomer-like subunits and also barrel-like arrangements that did not match the experimental dimensions.
The models matching the experimental criteria within the decamer and the dodecamer subgroups were
manually compared and four representative models from each of these sets were selected for future analysis.
At this stage, three models of the stab-1 HCC decamers were selected for further MD simulations as the
overall arrangement of subunits was different in each after the initial docking procedures. Interestingly, one
of these models was very unstable and lost its secondary and tertiary structures during the initial steps
of the MD simulations; it was therefore excluded from further studies. A similar approach was taken for
the dodecamer models, where just one dodecamer model was selected, which consisted of a very similar
arrangement of subunits to the selected decamer models. All the initial models of stab-1 HCC decamers and
dodecamers are shown in Supplementary Figure S2.
After selection of the starting models obtained from SymmDock, the fragment of the polypeptide
chain (Pro78-Asn79) that is missing in the 3GAX structure was built using Swiss-PdbViewer v4.1 [38],
and a domain exchange between neighboring units in the oligomers was implemented as shown
in Supplementary Figure S3. This exchange was based on the domain swap mechanism observed
in the native HCC crystal structures, in which the N-terminal fragment of the polypeptide chain
(residues 1–58) was transferred from the first stab-1 HCC subunit to the second one, with the rest of
the chain remaining unaltered [11–13]. With these additions, the models were used for the molecular
dynamics simulation step in AMBER.
2.4. Molecular Dynamic Simulations of the Stab-1 HCC Oligomers
After selecting the preliminary models as described above, we examined the structural and
conformational stabilities of these stab-1 HCC oligomers with molecular dynamics simulations using
the AMBER program package and the AMBER force field. To distinguish between the two decamer
models, we denote them as stab-1 HCC decamer model 1 and stab-1 HCC decamer model 2. Molecular
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dynamics simulations of the stab-1 HCC decamer model 1 and model 2 and the dodecamer model
were performed for a total of 50 ns per model. The changes in the potential energy of these systems as
a function of simulation time are shown in Supplementary Figure S4. Throughout the MD simulations,
the dodecamer model has a lower potential energy value compared to the models of the stab-1 HCC
decamers. This is indicative of a greater stability of this dodecamer oligomer model when compared to
the decamer models and suggests that it is the most energetically favored structure. After ca. 35 ns of
MD simulations, the subsequent changes in energy for all models is relatively small, even immediately
after the reduction in the positional constraints imposed on Cα, indicating the stabilization of the
energy parameters for the decamer and dodecamer structures.
For all the models studied here we also analyzed the changes in root mean squared deviations
(RMSD) during the simulations. The changes in the positions of Cα atoms within all the configurations
were compared to the coordinates in the initial model after minimization of the energies in solution.
The changes in RMSD for all three models are shown in Supplementary Figure S4b. The rapid increase in
RMSD values within the first 0.5 ns is likely to result from (i) bringing the system to the measurement
temperature, (ii) the necessity for the protein structure to adapt to the in silico domain exchange, and (iii)
the necessity of the initial structures to adapt after the transfer of the model, based on the protein structure
from the crystallographic data environment, into solution by applying an implicit solvent model.
The potential energy and RMSD plots possess a step-like characteristic as a result of the stepwise
reduction in the strength of the restraints imposed on the Cα atoms. Over the entire MD simulations,
the change in RMSD values for decamer model 1, model 2 and the dodecamer were 3.84 Å, 4.05 Å
and 4.35 Å, respectively. The observed changes in RMSD are related to the presence of a number of
conformational transformations within the native state of the protein in solution [39], and the larger
initial conformational changes are likely to be due to local reorganization resulting from the domain
exchange incorporated in the initial models. In all cases, the trajectory of the RMSD values stabilized
throughout the time course of the MD simulations.
To complement these molecular dynamics simulations (time scale 50 ns), we performed
canonical molecular dynamics using a scale-consistent UNitedRESidue (UNRES) course-grained
force field [40–42]. This allowed us to do the simulations on a much longer time-scale (3 µs) and we
report the RMSD trajectories along with the TM-scores, which are the scoring function for automated
assessment of protein structure template quality. TM-scores allow evaluation of structural predictions,
and it has no bias due to the target protein’s length or size and uses all the residues of the modeled
proteins in the evaluation of the score [43]. Simulations performed at 277 K and 300 K are shown in
Supplementary Figures S5 and S6, and we found that after 3 µs at 277 K, the TM-scores were 0.52, 0.46
and 0.47, and at 300 K, all three models exhibit similar TM-scores of 0.46, 0.43 and 0.43, for the dodecamer,
decamer model 1 and decamer model 2, respectively. Therefore, as with our shorter-scale simulations,
the most stable model was the dodecamer and we note that out of the 288 trajectories performed,
no dissociation was observed (see comparison of the final structures in Supplementary Figures S7
and S8). We further confirmed, using longer all-atom simulations, without any restraints, in explicit
solvent, that decamer model 1 and the dodecamer are stable (Supplementary Figure S9). The RMSD
for decamer model 1 rose during the simulation to 7 Å, while the RMSD for the dodecamer rose to
16 Å. The lower value for decamer model 1 revealed a higher stability for this structure as it remained
virtually unchanged during the simulations (Supplementary Figure S10a), whereas the dodecamer
shows signs of bending over the time course (Supplementary Figure S10b). Decamer model 2 was
found to be unstable during the all-atom simulations. Despite the fact that the order of stability for
decamer model 1 and the dodecamer differs between the all-atom simulations and the coarse-grained
simulations, both methods confirm that there is no dissociation with either of these two models.
After the simulations, it was clear that the increase in RMSD is largely related to changes in the
secondary structure within the oligomer models, as the tertiary structure and the overall shape, size
and position of the stab-1 HCC monomer-like subunits within the oligomers do not change significantly
(Figure 4A). For all the models of the stab-1 HCC oligomers, a partial loss of the secondary structure
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is particularly evident within the β2 sheet and the L1 loop, which participates in domain swapping
(Figure 4B). It is also notable that after MD simulations, the area where an additional disulfide bridge
(L47C-G69C) links β2 sheet with β3 sheet has lost its secondary structure. This points to the importance
of maintaining the structural stability within this region to prevent HCC fibril formation, and in turn
may explain why the pathological L68Q mutation, which reduces the structural stability in this area,
has a large impact on the acceleration of aggregation and the formation of HCC amyloid fibrils.
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Figure 4. Models of the stab-1 HCC oligomers after MD simulations. (A) Final models of HCC:
decamers (left—model 1, center—model 2) and dodecamer (right) obtained in the MD simulations.
An enlargement of one subunit within the initial models (color) is superimposed nto th final structures
(grey). (B) An HCC monomer-like subunit from the dodecamer model after MD simulations, labelled
with the locations of the secondary structure elements as found in the crystal structure. The oligomer
molecule is formed after a domain exchange: main chain 1—light gray, main chain 2—purple. In the
crystal structure, there is an additional disulfide bridge (L47C-G69C) linking β2 sheet with β3 sheet
(residues indicated in yellow) and the position of residue L68 is labelled in red; this is the location of
the pathogenic mutation, L68Q. The appending structure (AS) is the broad random-coil region between
the β3 and β4 sheets [12].
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Thus, the structure of the entire subunit changes after domain swapping and results in the
formation of a loop in place of the β sheet structure of the native state. A comparison of the secondary
structure content within the final oligomer models to that of the stab-1 HCC monomer (PDB code:
3GAX) and the HCC dimer (PDB code: 1G96) is shown in Table 2. The highest degree of secondary
structure within the polypeptide chain is present in decamer model 1, with decamer model 2 having
the largest disruption to the secondary structure elements relative to the native monomer and dimer,
containing a random coil fraction of 43% [12,31].
Table 2. Secondary structure content of the proposed stab-1 HCC oligomer structures calculated using
the STRIDE web server [44] and compared with values derived from the crystal structure of the stab-1
HCC monomer (PDB code: 3GAX; [14]) and the HCC dimer (PDB code: 1G96; [12]).
Secondary Structure
Element
3GAX
(Monomer)
1G96
(Dimer) Dodecamer
Decamer
Model 1
Decamer
Model 2
α-helices 17% 18% 17.8% 16.9% 15.1%
β-sheets 45% 36% 21.3% 25.3% 22.2%
turns 11% 19% 26.6% 28% 19.7%
coil 27% 27% 34.3% 29.9% 43%
Analysis of the structures of the individual oligomer models show that the greatest structural
changes occur within decamer model 2 (see Tables 2 and 3). In comparison to the initial model used for
the MD simulations, the outer edge of this model has shifted to the interior of the oligomer structure,
creating a bowl shape. The height of this oligomer also increases to 3.5 nm, a value that is higher than
estimated from AFM measurements (1.6–2.4 nm). In contrast, the diameter of decamer model 2 is
0.5 nm smaller than that observed for decamer model 1. Overall, the HCC dodecamer is the most
energetically stable structure in the MD simulations and the dimensions of the proposed model are in
closest agreement with the structural parameters of the circular oligomers obtained from experimental
studies (TEM, AFM and SAXS) (Table 3).
Table 3. Structural parameters of models of the stab-1 HCC oligomers after MD simulations.
Decamer Model 1 Decamer Model 2 Dodecamer
Outer Diameter (nm) 12.0 11.5 13.8
Inner Diameter * (nm) 4.8 5.1 4.8
Height (nm) 2.3 3.5 2.5
* Inner diameter is defined as the distance between the internal cavity and the outer ring structure.
The conformational stability of the oligomers and their secondary structure depends on the
presence of arrays of hydrogen bond networks that not only stabilize the structure of the particular
subunits, but which are also observed to form between different subunits via domain swapping;
a key factor for the stability of the entire oligomeric structure. For the dodecamer model, stable
hydrogen bonds between two domains within the same subunit are formed between Asp65-Arg51
(OD2-HH22-NH2), and are present for 78.4% of the MD simulation time; domain-swapped hydrogen
bonds are, however, formed between two pairs of residues: Glu21-Arg51 (OE1-HH11-NH1) and
Pro105-Asn61 (O-HD22-ND2) and are present for 84% and 72% of the MD simulations, respectively
(Figure 5). The presence of domain-swapped hydrogen bonds is indicative of the high stability of the
dodecamer model.
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3. Discussion
As a result of the good correlation between the MD simulations and the experimental parameters
measured by AFM, TEM and SAXS, we propose a model of the stab-1 HCC oligomers in solution as a
doughnut-like dodecamer structure. This dodecamer structure is the most energetically favored of the
three models we have examined. Although a small population of larger, cyclic species, as well as short
fibrils, have been observed sporadically in TEM images, the majority of the species we have observed
experimentally fit well with this proposed dodecamer model.
It is interesting to note that these stabilized HCC oligomers, which do not readily form fibrillar
species, maintain a significant degree of native-like structure. Such maintenance of native-like structure
has also been reported for WT HCC oligomeric species formed under non-denaturing conditions [45].
These reported oligomers retain native secondary structure and both papain and legumain enzymatic
inhibitory function and appear to be non-domain-swapped species, but unlike our stabilized oligomers,
the average size of those species is that of a trimer [45]. Interestingly, stabilized oligomers from another
member of the cystatin superfamily, stefin B (or cystatin B), have been observed and characterized
as domain-swapped tetrameric oligomers which are stabilized by a “hand-shake mechanism” [46].
As such, Pro74 is in the cis form (opposed to the trans form normally adopted in the monomer), and this
causes domain-swapped dimers to become intertwined. Like the stab-1 HCC oligomers, the reported
trimeric non-domain-swapped oligomers as well as the stefin B oligomers do not readily proceed to
fibril formation of cystatin C [16,41,45,46]. What is also worth mentioning is that the introduction of
the additional disulfide bridge (L47C-G69C), linking the β2 sheet with the β3 sheet in the legumain
binding site region within the HCC monomer, is important for stabilizing the structure against amyloid
formation. Interestingly, mutations that reduce the structural stability in this area, like the pathological
L68Q mutation, will have a large impact on the acceleration of aggregation and the formation of HCC
amyloid fibrils.
The stab-1 HCC aggregates analyzed in this study can be isolated and are relatively stable in
solution, and this has enabled the detailed study of their structural nature. Using experimental
measurements and D simulations, we propose a dodecamer structural model of the stab-1 HCC
doughnut-like oligomers. Given the generic property of proteins to form amyloid fibrils, mounting
evidence that the formation of oligomers is also a commonality amongst diverse substrates is increasing
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and interestingly, along with oligomers isolated from intrinsically disordered proteins, such as Aβ
peptides and α-synuclein, a number of structural studies have been reported for oligomers formed by
proteins which have globular native structures, such as hen egg-white lysozyme, transthyretin, HypFN,
acylphosphatase and cystatin C [47–50]. The identification of ring-shaped oligomers that interact with
lipid bilayers and act as ion channels has been reported for amyloid proteins associated with various
neurodegenerative disorders, including Alzheimer’s [32], Parkinson’s [33] and prion [51] diseases.
It is suggested that such oligomers can cause disruption or rupturing of the lipid membrane, thereby
allowing excessive ion influx, which is toxic to the cells. The above theory may explain the mechanism
of cytotoxicity of non-fibrillar protein oligomers in neurodegenerative diseases [33]. The oligomers of
amyloid proteins (also human cystatin C [16]) share a unique epitope structure that is detectable by
the A11 antibody (anti-amyloid β antibody), which highlights the similarities in the structure of the
oligomers of other disease-related oligomers, regardless of differences in their amino acid sequence [18].
With the growing importance of understanding the biological significance of this oligomeric species,
the structural information presented here on stab-1 HCC oligomers provides further information on
the nature of such species.
4. Materials and Methods
4.1. Production of Stabilized Oligomers
Covalently stabilized oligomers of human cystatin C (stab-1 HCC) were produced and purified
as described previously [16] and the samples for transmission electron microscopy and atomic force
microscopy measurements were isolated by size-exclusion gel chromatography as previously detailed,
and kept in sodium bicarbonate buffer (50 mM, pH 7.8, 4 ◦C) prior to imaging.
4.2. Transmission Electron Microscopy
Stab-1 HCC oligomer solutions (3–5µL) for characterization by TEM were applied to carbon-coated
400 mesh nickel grids (TAAB Laboratory Equipment Ltd., Aldermaston, UK), allowed to adsorb for
60 s and then blotted using filter paper. Samples were stained with 2% (w/v) uranyl acetate for 30 s,
and washed with deionized water. The samples were imaged on a FEI Tecnai G2 transmission electron
microscope at the Cambridge Advanced Imaging Centre (CAIC), University of Cambridge, UK. Images
were recorded using the SIS Megaview II Image Capture System (Olympus, Tokyo, Japan). Analysis of
the resulting TEM images was performed using ImageJ [52].
4.3. Atomic Force Microscopy
Topographic images of the oligomers were collected using a NanoWizard AFM system
(JPK Instruments AG, Berlin, Germany). Purified samples were first diluted in deionized water
by a factor of 1000–5000 to give concentrations of ~2–10 pM. These solutions (5–10 µL) were placed
on freshly prepared mica surfaces, adsorbed for 10–20 min, gently washed with small amounts of
deionized water and dried using nitrogen gas. AFM imaging was performed in the intermittent (air)
contact mode using a silicon nitride cantilever. The analysis of the images was carried out using
Gwyddion 2.45 software [53].
4.4. Small Angle X-ray Scattering
The small angle X-ray scattering (SAXS) data for solutions of stab-1 HCC oligomers (1.1 mg/mL)
were collected on the BioSAXS X33 bending magnet beamline, operated by EMBL [54,55] at the DORIS
III storage ring of DESY (Hamburg, Germany). The experiments were conducted in a standard manner
using an autosampler, a hybrid photon counting detector (Pilatus 1M-W, Dectris, Baden-Daettwil,
Switzerland) and synchrotron radiation (λ = 0.15 nm). The data were processed using PRIMUS [56]
from the ATSAS package [57], and the radius of gyration (Rg) was calculated by fitting of the SAXS
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data in the s-range from 0.124 to 0.247 nm−1 (sRg < 1.3, s = 4pisinθ/λ, where θ is a scattering angle) to
the Guinier equation (Equation (1))
I(s) = I(0)e
−s2Rg2
3 (1)
The universal Rg calculator [41] was used to define the geometric parameters of the images that
best depicted the shape of doughnut-like oligomers.
4.5. Molecular Dynamics Simulations
4.5.1. Preparation of Initial Models
Preliminary models of stab-1 HCC decamers and dodecamers were constructed using the crystal
structure of the stab-1 HCC monomer (PDB: 3GAX) [14]. The subunits (HCC monomers) were
assembled into oligomers using the docking server SymmDock [37]. For the construction of the initial
atomic models of the oligomers, two types of oligomers containing 10 and 12 monomer-like subunits
were defined on the basis of previous gel filtration analysis [16], and the structures of the oligomers
were obtained by the geometrical matching of the given subunits in space. The parameters (oligomer
diameter, height and inner cavity diameter) determined from the TEM and AFM measurements were
used as the initial geometric parameters. These dimensions suggest that the rings are composed of
individual monomer-like subunits arranged in a circular shape. From the final set of 100 structures
for each oligomer type produced using SymmDock, only those models satisfying the experimental
geometrical and structural conditions were considered further. Once these models were selected, a
fragment of the polypeptide chain (Pro78-Asn79), for which electron density is missing in the X-ray
structure (3GAX), was built using Swiss-pdb Viewer 4.1, and the exchange of the subdomains, up to
position Ala58, was implemented manually according to the domain-swapping mechanism observed
in the native HCC crystal structure [11–13]. The domain swapping was implemented intermolecularly
throughout the oligomer; therefore we manually broke the bond between residue 58 and 59 to allow
the transfer of residues 1–58 from one subunit to the next. Due to this broken bond in these initial
models, larger positional restraints were imparted at the beginning of the MD simulations. The atomic
positions of the residues in the N-terminal segment of the polypeptide chain (residues 1–58) were
transferred from the first stab-1 HCC monomer-like subunit to the second one, with the rest of the first
chain remaining unaltered. This phase of the modeling was conducted in JOE (operating in the Linux
environment). Analogous procedures were performed for all subunits in the selected models of the
stab-1 HCC decamers and dodecamers prior to the molecular dynamics simulations in AMBER.
4.5.2. Simulations Using AMBER
Molecular dynamics simulations of the doughnut-like oligomers (decamers and dodecamers) were
carried out using the PMEMD module of the program SANDER from the AMBER 12 package [58,59],
employing the graphics processing units (GPUs) [59]. Preliminary minimizations of the initial
oligomeric structures were performed in two steps, the first involving minimization in vacuo and the
second in implicit solvent. Each minimization cycle was completed within 10,000 steps, where each step
was 2 fs in duration, and both the minimization steps and the molecular dynamics simulations were
conducted in the presence of restraints. As the domain swapping process was carried out manually,
no bonds were imposed at position 58 (in any subunit), nor for the two amino acids on either side of this
residue (i.e., Ile56 and Val57, Gly59 and Val60), thereby permitting slow relaxation of the structure in
the area closest to the domain exchange region that is located in the L1 loop (i.e., within the Ile56-Val60
segment). During the molecular dynamics simulations, the strength of these positional restraints was
gradually reduced from an initial value of 20 kcal/mol to a final value of 0.3 kcal/mol.
During the second cycle of minimization, the MD simulations of the stab-1 HCC oligomers were
carried out in implicit solvent (considering it to be an infinite medium, with specific properties related
to water, such as the dielectric constant). The solvation model was described by the Born model as
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generalized in the Hawkins, Cramer, Truhlar approach [60,61], using the parameters provided by
Tsui and Case [62]. The lengths of the hydrogen bonds were maintained at constant values using the
SHAKE algorithm, and for all of the oligomers the temperature was kept at 300 K and was regulated
by the Berendsen algorithm [63].
The total time for the simulation of each oligomer was 50 ns (i.e., 25 million steps), but the
simulation procedure was split into several cycles. After each cycle, a model of the stab-1 HCC
oligomer was generated and the positional restraints imposed on the Cα atoms were gradually reduced
from 20 to 0.5 kcal/mol in the time range 0–35 ns, and to 0.3 kcal/mol in the time range of 35–50 ns.
The MD simulations were continued until the energy of the system reached equilibrium.
The analysis of the oligomer models obtained during MD simulations involved (i) analysis of the
trajectory (RMSD) performed using ptraj from the AMBER package, (ii) analysis of the hydrogen bonds
using cpptraj from the AMBER package, (iii) analysis of the secondary structure using the STRIDE web
server [44], and (iv) analysis of the potential energy and temperature using the process_mdout.perl
script (AMBER) to extract the information from the MD output files. Visual representations of the
structures of the oligomers were generated using PyMOL (The PyMOL Molecular Graphics System,
Version 1.5.0.4 Schrödinger, LLC, Mannheim, Germany).
4.5.3. Canonical Molecular Dynamics with use of the Scale-Consistent UNitedRESidue (UNRES)
Coarse-Grained Force Field
To determine the stability of the obtained models, we performed canonical molecular dynamics
using the scale-consistent United RESidue (UNRES) coarse-grained force field as described
previously [42]. We performed simulations at two temperatures: 277 K (experimental temperature)
and 300 K (room temperature) with 48 trajectories for each system and each temperature. For both
temperatures, we performed 6 million step simulations with 0.498 fs time steps that correspond to
3 ns of UNRES time which, after compensating for the speed due to coarse-graining, corresponds
to ~3 µs of real-time [64,65]. Langevin thermostat was used and the friction factor was scaled down
by 100 to speed up the simulations. To prevent eventual reassociation of the dissociated multimers,
the box size was set to 800 Å × 800 Å × 800 Å. Root mean square deviation (RMSD) measurements and
TM-scores [43] were used to estimate the stability of the models.
4.5.4. All-Atom Simulation with the AMBER ff14SB Force Field
The all-atom simulations were performed with the AMBER ff14SB force field. The model protein
was placed in a cuboid box in TIP3P explicit water. The size of the box was the size of the protein
with an additional 10 Å from each side for decamer model 1 and 20 Å from each side for decamer
model 2 and the dodecamer model, as the latter have larger sizes. The energy was minimized with
a protocol that consisted of (i) restrained energy minimization with Cα-distance restraints derived
from the appropriate model and on the backbone dihedral angles from the regions of regular α-helical
and β-sheet structure, followed by (ii) a short restrained MD simulation with the same restraints.
Subsequently, the short NPT simulation was performed and afterwards a 100 ns NVT production run
was performed.
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